Litcius/Paper detail

Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study

Airi Fujimoto, Yoshimichi Koutake, Daisuke Hisamatsu, Noriko Ookubo, Yurika Yabuuchi, Go Kamimura, Tatsuo Kai, Aki Kozono, Takahiro Ootsu, Hiroto Suzuki, Keisuke Matsuo, Kimiko Kuwahara, Yoshita Oiwane, Yuko Nagata, Kenya Tanimoto, Eri Sato, Mei Suenaga, Tomohiro Uehara, Akira Ikari, Satoshi Endo, Yoichi Hiraki, Yosei Kawamata

2023Cancer Immunology Immunotherapy11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineInternal medicineLung cancerOncologyOdds ratioAdverse effectRetrospective cohort studyConfidence intervalChemotherapyCancerImmunologyCancer Immunotherapy and BiomarkersLung Cancer Research StudiesInflammatory Biomarkers in Disease Prognosis
Risk factors indicating immune-related adverse events with combination chemotherapy with immune checkpoint inhibitors and platinum agents in patients with non-small cell lung cancer: a multicenter retrospective study | Litcius